Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer
NCT00535015 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2008-07-22
Summary
The purpose of this study is to determine whether Betamarc is effective in improving the appetite and reversing weight loss in patients with advanced Non-Small Cell Lung Cancer.
Conditions
- Anorexia
- Cachexia
- Weight Loss
- Carcinoma, Non-Small-Cell Lung
Interventions
- DRUG
-
Betamarc
2 tabs BID
Sponsors & Collaborators
-
Anaborex
lead INDUSTRY
Principal Investigators
-
Yung-chuan Sung · Cathay General Hospital
-
Hsing-jin Eugene Liu · Taipei Medical University Muncipal Wan Fang Hospital
-
Te-chun Hsia · China Medical University Hospital
-
Gee-chen Chang · Taichung Veterans General Hospital
-
Yao-kuang Wu · Tzu Chi General Hospital Taipei Branch
-
Kwok-keung Yuen · Tuen Mun Hospital
-
Daniel Chua · Queen Mary Hospital, Hong Kong
-
Chung-kong Kwan · The Queen Elizabeth Hospital
-
Kwok-chi Lam · Prince of Wales Hospital
-
Dae-ho Lee · Asan Medical Center
-
Jong-seok Lee · Seoul National University Bundang Hosptial
-
Hoon-kyo Kim · Saint Vincent's Hospital, Korea
-
Jin-hyoung Kang · The Catholic University of Korea, St. Mary's Hospital
-
Anita Zarina binti Bustam · University of Malaya
-
Abdul Razak bin Abdul Muttalif · Penang Hospital, Malaysia
-
Biswa Mohan Biswal · Hospital Universiti Sains Malaysia
-
Wu-chou Su · National Cheng-Kung University Hospital
-
Ming-lin Ho · Chunghua Christian Hospital
-
Chang-yao Tsao · Chung Shan Medical University
-
Cheng-ta Yang · Chang Gung Memorial Hospital, Chiayi
-
Wen-Tsung Huang · Chi Mei Medical Center Liou-Ying Campus
-
Edy Suratman · Dharmais Cancer Hospital
-
Elisna Syahruddin · Persahabatan Hospital
-
Alexander Ginting · Gatot Subroto Central Army Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2008-06-30
- Completion
- 2008-08-31
Countries
- China
- Taiwan
Study Locations
More Related Trials
-
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
NCT05340491 ·Status: RECRUITING ·Phase: PHASE3
-
Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer
NCT05269485 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC
NCT05261438 ·Status: COMPLETED
-
The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study
NCT03637634 ·Status: NOT_YET_RECRUITING
-
Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617
NCT04801264 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC Subjects
NCT03121716 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1，Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors
NCT05315180 ·Status: UNKNOWN ·Phase: PHASE1
-
Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain
NCT05304468 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
NCT07150663 ·Status: RECRUITING ·Phase: PHASE3
-
A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01)
NCT06118333 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma
NCT01534585 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma
NCT05385926 ·Status: RECRUITING ·Phase: PHASE2
-
A Clinical Study of SI-B001 in Combination With Paclitaxel in the Treatment of Recurrent and Metastatic HNSCC
NCT05054439 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Conventional and Low-dose Platinum Gemcitabine Combined With Cindilimab With Delayed Administration in First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer
NCT05312840 ·Status: UNKNOWN ·Phase: PHASE4
-
Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients
NCT02973386 ·Status: COMPLETED ·Phase: PHASE3
-
Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma
NCT07248956 ·Status: RECRUITING ·Phase: PHASE2
-
The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
NCT01797900 ·Status: COMPLETED ·Phase: PHASE2
-
Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma
NCT03175939 ·Status: COMPLETED ·Phase: PHASE2
-
Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)
NCT01712919 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma
NCT04769076 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer
NCT01494558 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC.
NCT03210389 ·Status: UNKNOWN ·Phase: PHASE2
-
68Ga-FAPI-46 PET/CT for the Prediction of Clinical Response to Neoadjuvant Therapy in Nasopharyngeal Carcinoma Patients
NCT07139054 ·Status: COMPLETED
-
Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer
NCT04137588 ·Status: UNKNOWN
-
Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC
NCT05549466 ·Status: UNKNOWN ·Phase: PHASE2